Soleno Therapeutics SLNO 深 沪
等待开盘 10-03 09:30:00 美东时间
57.98
-2.140
-3.56%
华盛通- 最 高60.2684
- 今 开59.82
- 成交量 212.21万股
- 最 低 55.78
- 昨 收 60.12
- 总市值 30.58亿
- 52周最高 90.3199
- 市盈率 静 --
- 换手率 4.02%
- 52周最低 41.50
- 委 比 -53.66%
- 总股本 5274.69万
- 历史最高 90.3199
- 量 比 1.18
- 振 幅 7.47%
- 历史最低 1.81
- 每 手 1
- 风险率 7.94%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Acadia Pharma Faces Trial Setback As Prader-Willi Syndrome Trial Falls Short
Acadia's Phase 3 Compass Prader-Willi syndrome trial failed to meet endpoints, but the company projects $1 billion in sales in 2025 and highlights a strong pipeline outlook.
09-24 22:05
Acadia slumps after trial setback for Prader-Willi syndrome drug; Soleno jumps
Acadia Pharma (NASDAQ:ACAD) shares fell in the premarket on Wednesday after the biotech announced that its experimental therapy for a rare genetic condition known as Prader-Willi syndrome failed in a ...
09-24 20:05
美股周涨跌榜 | 好莱坞或迎巨震！华纳兄弟探索频道周涨超55%；新思科技绩后暴跌28.9%
好莱坞或迎巨震！华纳兄弟探索频道周涨超55%，传Paramount Skydance拟收购公司；新思科技绩后暴跌28.9%>>
09-13 11:42
Soleno Therapeutics Addresses FDA Adverse Event Report
The latest update is out from Soleno Therapeutics ( ($SLNO) ). Soleno Therapeut...
09-11 00:59
Guggenheim Reiterates Buy on Soleno Therapeutics, Maintains $106 Price Target
Guggenheim analyst Debjit Chattopadhyay reiterates Soleno Therapeutics (NASDAQ:SLNO) with a Buy and maintains $106 price target.
08-27 22:02
Soleno Therapeutics to Participate in Upcoming September Conferences
Soleno Therapeutics will participate in several investor conferences in September 2025, including Cantor Global Healthcare Conference (September 3), Wells Fargo Healthcare Conference (September 4), H.C. Wainwright Global Investment Conference (September 8), Baird Global Healthcare Conference (September 9), and Bernstein Healthcare Forum (September 25). All events will feature Fireside Chat presentations. Replays of the Cantor and Wells Fargo even...
08-27 12:00
Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman
SAN FRANCISCO, Aug. 20, 2025 /PRNewswire/ -- On August 15, 2025, shares in Soleno Therapeutics, Inc. (NASDAQ: SLNO) experienced a significant drop following the release of a highly critical ...
08-21 04:02
Soleno Therapeutics Engages Investors in Roadshow
Soleno Therapeutics ( ($SLNO) ) has issued an announcement. During August 18-19...
08-18 19:16
Soleno Under Serious Scrutiny As Short Seller Alleges PWS Drug Is Overpriced, Unsafe
Children were reportedly hospitalized after starting treatment. Scorpion Capital suggests Soleno's medication could face market withdrawal.
08-16 01:30
